OverviewSuggest Edit

ViewRay is a company that designs, manufactures, and markets MRIdian, an MRI-guided radiation therapy system. Its solution integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of soft-tissue tumors while radiation is delivered. MRIdian allows physicians to record the level of radiation exposure that the tumor has received and adapt the prescription as needed.

TypePublic
Founded2004
HQOakwood Village, OH, US
Websiteviewray.com
Employee Ratings3

Latest Updates

Employees (est.) (Dec 2019)309(+40%)
Job Openings15
Revenue (FY, 2020)$57 M(-35%)
Share Price (May 2021)$5
Cybersecurity ratingDMore

Key People/Management at ViewRay

Scott Drake

Scott Drake

President and Chief Executive Officer
Shahriar Matin

Shahriar Matin

Chief Operating Officer
Stephen Strunk

Stephen Strunk

Vice President
James F. Dempsey

James F. Dempsey

Chief Scientific Officer
Rob Fuchs

Rob Fuchs

Chief Human Resources Officer
Robert McCormack

Robert McCormack

Senior Vice President, General Counsel and Corporate Secretary
Show more

ViewRay Office Locations

ViewRay has offices in Oakwood Village and Mountain View
Oakwood Village, OH, US (HQ)
2 Thermo Fisher Way
Mountain View, CA, US
815 E Middlefield Rd
Show all (2)

ViewRay Financials and Metrics

ViewRay Revenue

ViewRay's revenue was reported to be $57.02 m in FY, 2020
USD

Revenue (Q1, 2021)

15.5m

Gross profit (Q1, 2021)

322.0k

Gross profit margin (Q1, 2021), %

2.1%

Net income (Q1, 2021)

(26.7m)

EBIT (Q1, 2021)

(24.7m)

Market capitalization (13-May-2021)

807.1m

Closing stock price (13-May-2021)

5.0

Cash (31-Mar-2021)

182.0m

EV

682.1m
ViewRay's current market capitalization is $807.1 m.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

10.4m22.2m34.0m81.0m87.8m57.0m

Revenue growth, %

62%114%

Cost of goods sold

14.5m25.9m27.7m74.4m93.3m61.1m

Gross profit

(4.2m)(3.6m)6.3m6.6m(5.5m)(4.1m)
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

5.3m5.5m299.0k357.0k1.2m698.0k12.2m26.2m16.4m17.7m20.3m30.2m20.9m14.3m14.2m10.1m15.5m

Cost of goods sold

6.1m6.5m863.0k1.2m1.0m826.0k10.2m20.6m16.4m17.3m25.6m26.9m20.3m16.4m15.3m11.2m15.2m

Gross profit

(775.0k)(1.1m)(564.0k)(826.0k)185.0k(128.0k)2.0m5.6m69.0k364.0k(5.4m)3.2m574.0k(2.1m)(1.0m)(1.1m)322.0k

Gross profit Margin, %

(15%)(20%)(189%)(231%)15%(18%)16%21%0%2%(26%)11%3%(15%)(7%)(11%)2%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

11.1m20.7m14.2m57.4m167.4m226.8m156.7m

Accounts Receivable

904.0k830.0k4.2m20.3m36.9m16.8m11.8m

Prepaid Expenses

4.9m6.0m3.3m5.3m

Inventories

8.2m8.1m8.1m19.4m49.5m55.0m46.6m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(33.8m)(45.0m)(50.6m)(72.2m)(76.4m)(120.2m)

Depreciation and Amortization

1.0m1.3m1.7m2.2m3.5m4.7m6.4m

Inventories

(703.0k)(1.7m)(12.3m)(32.2m)(6.0m)8.2m

Accounts Payable

(2.1m)381.0k6.3m(870.0k)2.8m(3.4m)
USDQ2, 2014

Financial Leverage

-1.1 x
Show all financial metrics

ViewRay Operating Metrics

ViewRay's Backlog was reported to be 133.2m in FY, 2016.
FY, 2016

Backlog

133.2 m

Patents (Foreign)

31

Patents (US)

19

Patents Pending

108
Show all operating metrics

ViewRay Revenue Breakdown

Embed Graph

ViewRay revenue breakdown by geographic segment: 24.7% from Netherlands, 22.9% from Italy, 46.7% from Japan and 5.8% from Other

ViewRay Cybersecurity Score

Cybersecurity ratingPremium dataset

D

69/100

SecurityScorecard logo

ViewRay Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

ViewRay Online and Social Media Presence

Embed Graph

ViewRay News and Updates

Penn State Health Purchases Second ViewRay MRIdian® Linac

CLEVELAND, Feb. 11, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Penn State Health has purchased a second MRIdian Linac joining other pioneering institutions from around the globe investing in multiple MRIdian systems. Penn State Health's first MRIdian Linac will...

The Henry Ford Cancer Institute Installs its Second ViewRay MRIdian® Linac

CLEVELAND, Jan. 26, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Henry Ford Cancer Institute has installed its second MRIdian Linac at its new cancer pavilion, Henry Ford Cancer Institute – Detroit, which began offering patient care on January 20, 2021. Following...

ViewRay Announces Preliminary Fourth Quarter and Full Year 2020 Results

CLEVELAND, Ohio, Jan. 4, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced preliminary results for the fourth quarter and full fiscal year ended December 31, 2020. The preliminary results have not been audited and are subject to change. Selected Fourth Quarter and Full...

ViewRay to Present at the 39th Annual J.P. Morgan Healthcare Conference

CLEVELAND, Dec. 23, 2020 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced its participation in the 39th Annual J.P. Morgan Healthcare Conference. Scott Drake, President and CEO, is scheduled to present at 10:50 a.m. Eastern Time on Thursday, January 14, 2021. An audio webcast...

ViewRay Reports Third Quarter 2020 Results

CLEVELAND, Nov. 5, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced financial results for the third quarter ended September 30, 2020. Third Quarter 2020 Highlights: Total revenue of $10.1 million, primarily from one revenue unit, compared to $20.9 million,...

ViewRay, GenesisCare and the University of Oxford Announce Groundbreaking Compassionate Access Programme Now Open to UK Patients with Localized Pancreatic Cancer

ViewRay, Inc. (Nasdaq: VRAY) announced today that the GenesisCare Foundation's Compassionate Access Programme is now accepting patients for treatment on the MRIdian® MRI-Guided Radiation Therapy System. The program, in collaboration with the.
Show more

ViewRay Blogs

ViewRay Reports First Quarter 2021 Results

CLEVELAND , May 6, 2021 /PRNewswire/ --   ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced financial results for the first quarter ended March 31, 2021 . First Quarter 2021 Highlights Received seven new orders for MRIdian systems totaling $40.9 million , compared to four new orders

ViewRay Announces Conference Call for First Quarter 2021 Financial Results to be Held After Market on May 6, 2021

ViewRay Announces Conference Call for First Quarter 2021 Financial Results to be Held After Market on May 6, 2021 Content Import Mon, 04/19/2021 - 16:02 ViewRay Announces Conference Call for First Quarter 2021 Financial Results to be Held After Market on May 6, 2021 04/19/21…

ViewRay Announces Departure of Chief Operating Officer

CLEVELAND , March 15, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) ("the Company") today announced that Shahriar Matin , Chief Operating Officer, will leave the Company effective March 31, 2021 . Matin was named Chief Executive Officer designate of Cordis in its recently announced divestiture

ViewRay To Participate in the 21st Annual Oppenheimer Healthcare Conference

ViewRay To Participate in the 21st Annual Oppenheimer Healthcare Conference Content Import Fri, 03/05/2021 - 16:01 ViewRay To Participate in the 21st Annual Oppenheimer Healthcare Conference 03/05/21 This release is a backfill from a News Wire G…

ViewRay Reports Fourth Quarter and Full Year 2020 Results

ViewRay Reports Fourth Quarter and Full Year 2020 Results Content Import Thu, 03/04/2021 - 16:02 ViewRay Reports Fourth Quarter and Full Year 2020 Results 03/04/21 This release is a backfill from a News Wire Earnings CLEVELAND, March…

ViewRay Announces Conference Call for Fourth Quarter and Full Year 2020 Financial Results to be Held After Market on March 4, 2021

CLEVELAND , Feb. 19, 2021 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its fourth quarter and full year 2020 financial results.     ViewRay will hold a conference call to discuss results on Thursday, March 4, 2021 at 4:30 p.m. ET / 1:30 p.m. PT .
Show more

ViewRay Frequently Asked Questions

  • When was ViewRay founded?

    ViewRay was founded in 2004.

  • Who are ViewRay key executives?

    ViewRay's key executives are Scott Drake, Shahriar Matin and Stephen Strunk.

  • How many employees does ViewRay have?

    ViewRay has 309 employees.

  • What is ViewRay revenue?

    Latest ViewRay annual revenue is $57 m.

  • What is ViewRay revenue per employee?

    Latest ViewRay revenue per employee is $184.5 k.

  • Who are ViewRay competitors?

    Competitors of ViewRay include Varian Medical Systems, Elekta and Accuray.

  • Where is ViewRay headquarters?

    ViewRay headquarters is located at 2 Thermo Fisher Way, Oakwood Village.

  • Where are ViewRay offices?

    ViewRay has offices in Oakwood Village and Mountain View.

  • How many offices does ViewRay have?

    ViewRay has 2 offices.